...
ilmn-img

Illumina Inc, Common Stock

ILMN

NSQ

$111.35

+$0.73

(0.66%)

1D
Industry: Life Sciences Tools & Services Sector: Health Care

Analyst Forecast

Price Chart

Key Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$17.74B
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
NM
Volume info-icon
This is the total number of shares traded during the most recent trading day.
1.76M
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
1.63M
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
1.19
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$89 L
$213.91 H
$111.35

About Illumina Inc, Common Stock

Illumina, Inc. offers sequencing- and array-based solutions for genetic and genomic analysis in the United States, Singapore, the United Kingdom, and internationally. It operates through Core Illumina and GRAIL segments. The company offers sequencing and array-based instruments and consumables, which include reagents, flow cells, and library preparation; whole-genome sequencing kits, which sequence entire genomes of various size and complexity; and targeted resequencing kits, which sequence exomes, specific genes, and RNA or other genomic regions of interest. It also provides whole-genome sequencing, genotyping, noninvasive prenatal testing, and product support services; and Galleri, a multi-cancer early detection test. In addition, the company is developing solutions to help accelerate cancer diagnoses, blood-based detection for minimal residual disease, and other post-diagnostic applications. The company serves genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and consumer genomics companies. It markets and distributes its products directly to customers, as well as through life-science distributors. Illumina, Inc. was incorporated in 1998 and is based in San Diego, California. more

Industry: Life Sciences Tools & ServicesSector: Health Care

Returns

Time FrameILMNSectorS&P500
1-Week Return-10.19%2.01%2.41%
1-Month Return-16.64%0.02%-0.39%
3-Month Return-19.22%-0.13%3.53%
6-Month Return4.08%15.09%20.14%
1-Year Return-42.68%10%27.84%
3-Year Return-70.73%20.87%29.57%
5-Year Return-64.91%75.76%96.12%
10-Year Return-22.31%191.22%231.45%

Financials

Dec '19Dec '20Dec '21Dec '22Dec '235YR TREND
Total Revenue3.54B3.24B4.53B4.58B4.50B[{"date":"2019-12-31","value":77.29,"profit":true},{"date":"2020-12-31","value":70.66,"profit":true},{"date":"2021-12-31","value":98.73,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":98.25,"profit":true}]
Cost of Revenue1.08B1.04B1.37B1.61B1.76B[{"date":"2019-12-31","value":61.14,"profit":true},{"date":"2020-12-31","value":58.86,"profit":true},{"date":"2021-12-31","value":77.95,"profit":true},{"date":"2022-12-31","value":91.59,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Gross Profit2.47B2.20B3.15B2.97B2.74B[{"date":"2019-12-31","value":78.22,"profit":true},{"date":"2020-12-31","value":69.85,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":94.23,"profit":true},{"date":"2023-12-31","value":87,"profit":true}]
Gross Margin69.63%68.01%69.69%64.83%60.92%[{"date":"2019-12-31","value":99.92,"profit":true},{"date":"2020-12-31","value":97.6,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":93.04,"profit":true},{"date":"2023-12-31","value":87.43,"profit":true}]
Operating Expenses1.48B1.62B3.28B7.15B2.97B[{"date":"2019-12-31","value":20.72,"profit":true},{"date":"2020-12-31","value":22.7,"profit":true},{"date":"2021-12-31","value":45.83,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":41.48,"profit":true}]
Operating Income985.00M393.00M(123.00M)(4.18B)(1.07B)[{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":39.9,"profit":true},{"date":"2021-12-31","value":-12.49,"profit":false},{"date":"2022-12-31","value":-424.26,"profit":false},{"date":"2023-12-31","value":-108.53,"profit":false}]
Total Non-Operating Income/Expense156.00M455.00M946.00M(8.84B)(67.00M)[{"date":"2019-12-31","value":16.49,"profit":true},{"date":"2020-12-31","value":48.1,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-934.88,"profit":false},{"date":"2023-12-31","value":-7.08,"profit":false}]
Pre-Tax Income1.12B856.00M884.00M(4.34B)(1.12B)[{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":76.57,"profit":true},{"date":"2021-12-31","value":79.07,"profit":true},{"date":"2022-12-31","value":-387.84,"profit":false},{"date":"2023-12-31","value":-99.91,"profit":false}]
Income Taxes128.00M200.00M122.00M68.00M44.00M[{"date":"2019-12-31","value":64,"profit":true},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":61,"profit":true},{"date":"2022-12-31","value":34,"profit":true},{"date":"2023-12-31","value":22,"profit":true}]
Income After Taxes990.00M656.00M762.00M(4.40B)(1.16B)[{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":66.26,"profit":true},{"date":"2021-12-31","value":76.97,"profit":true},{"date":"2022-12-31","value":-444.85,"profit":false},{"date":"2023-12-31","value":-117.27,"profit":false}]
Income From Continuous Operations990.00M656.00M762.00M(4.40B)(1.16B)[{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":66.26,"profit":true},{"date":"2021-12-31","value":76.97,"profit":true},{"date":"2022-12-31","value":-444.85,"profit":false},{"date":"2023-12-31","value":-117.27,"profit":false}]
Income From Discontinued Operations-----[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Net Income1.00B656.00M762.00M(4.40B)(1.16B)[{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":65.47,"profit":true},{"date":"2021-12-31","value":76.05,"profit":true},{"date":"2022-12-31","value":-439.52,"profit":false},{"date":"2023-12-31","value":-115.87,"profit":false}]
EPS (Diluted)6.584.505.962.120.87[{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":68.39,"profit":true},{"date":"2021-12-31","value":90.58,"profit":true},{"date":"2022-12-31","value":32.22,"profit":true},{"date":"2023-12-31","value":13.22,"profit":true}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

ILMN
Cash Ratio 0.76
Current Ratio 1.75
Quick Ratio 1.36

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

ILMN
ROA (LTM) -0.50%
ROE (LTM) -20.76%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

ILMN
Debt Ratio Lower is generally better. Negative is bad. 0.43
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.57
Debt/Equity The higher the number, the more leverage the business employs, the riskier the investment typically is. 1.75

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

ILMN
Trailing PE NM
Forward PE 129.87
P/S (TTM) 4.49
P/B 3.52
Price/FCF 430
EV/R 4.76
EV/Ebitda NM
PEG NM

News

Illumina Inc (ILMN) Q1 2024 Earnings Call Transcript Highlights: Navigating Challenges and ...

Illumina Inc (ILMN) Q1 2024 Earnings Call Transcript Highlights: Navigating Challenges and Seizing Growth Opportunities

3 May, 2024 a 8:12 am GuruFocus

ILMN Stock Earnings: Illumina Beats EPS, Beats Revenue for Q1 2024

Illumina (NASDAQ: ILMN ) just reported results for the first quarter of 2024. Illumina reported earnings per share of 9 cents. This was above the analyst estimate for EPS of 4 cents. The company reported revenue of $1.08 billion. This was 2.48% better than the analyst estimate for revenue of $1.05 billion. InvestorPlace Earnings is a project that leverages data from TradeSmith to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at editor@investorplace.com. More From InvestorPlace The #1 AI Investment Might Be This Company You’ve Never Heard Of Musk’s “Project Omega” May Be Set to Mint New Millionaires. Here’s How to Get In. Legendary Investor Predicts: “Forget A.I.

3 May, 2024 a 12:56 am InvestorPlace

Illumina reaffirms annual revenue forecast over continued sluggish demand

Illumina reiterated its 2024 revenue forecast on Thursday, expecting continued weak demand from its customers such as medical research labs and hospitals.

2 May, 2024 a 10:25 pm Reuters

Apple EPS $1.53 versus $1.50 exp. Revenues $90.75 billion versus 90.01 billion exp

Earnings Expectations: Earnings per share (EPS): $1.53 vs $1.50 expectations. BEAT Revenue: $90.75 vs $90.01 billion expectations: BEAT Performance by Business Unit: iPhone revenue: $45.96 billion versus $46.00 billion expectations Mac revenue: versus $6.86 billion expectations iPad revenue: $5.56 billion versus $5.91 billion expectations Wearables, home, and accessories revenue: $7.91 billion versus $8.08 billion expectations Services revenue: $23.87 billion versus $23.27 billion expectations Future Projections: Forecast for the current quarter: Approximately $83.23 billion in sales, representing a 1.8% annual growth. On China says: "I feel great that in a extraordinary competitive environment that we grew iPhone sales in mainland China." ------------------------------------------------------------------------------------------------------ In other earnings released after the close: DraftKings Inc (DKNG) Revenue: $1.17 billion (BEAT expectations of $1.12 billion) Note: Net income and Adj.

2 May, 2024 a 8:31 pm Forexlive

Illumina Inc. Q1 Earnings Summary

SAN DIEGO (dpa-AFX) - Below are the earnings highlights for Illumina Inc. (ILMN):Earnings: -$126 million in Q1 vs. $3 million in the same period last year. EPS: -$0.79 in Q1 vs. $0.02 in the same …

2 May, 2024 a 8:30 pm Finanz Nachrichten

FAQs

What is Illumina Inc share price today?

Illumina Inc (ILMN) share price today is $111.35

Can Indians buy Illumina Inc shares?

Yes, Indians can buy shares of Illumina Inc (ILMN) on Vested. To buy Illumina Inc from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in ILMN stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Illumina Inc be purchased?

Yes, you can purchase fractional shares of Illumina Inc (ILMN) via the Vested app. You can start investing in Illumina Inc (ILMN) with a minimum investment of $1.

How to invest in Illumina Inc shares from India?

You can invest in shares of Illumina Inc (ILMN) via Vested in three simple steps:

  • Click on Sign Up or Invest in ILMN stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Illumina Inc shares
What is Illumina Inc 52-week high and low stock price?

The 52-week high price of Illumina Inc (ILMN) is $213.91. The 52-week low price of Illumina Inc (ILMN) is $89.

What is Illumina Inc price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Illumina Inc (ILMN) is NM

What is Illumina Inc price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Illumina Inc (ILMN) is 3.52

What is Illumina Inc dividend yield?

The dividend yield of Illumina Inc (ILMN) is 0.00%

What is the Market Cap of Illumina Inc?

The market capitalization of Illumina Inc (ILMN) is $17.74B

What is Illumina Inc’s stock symbol?

The stock symbol (or ticker) of Illumina Inc is ILMN

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top